EQS-News: Resolutions of the Annual General Meeting 2023 on the Financial Year 2021/2022 of BRAIN Biotech AG
Zwingenberg (Germany), 8 March, 2023 – At the Annual General Meeting of BRAIN Biotech AG today (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), shareholders approved all proposals of the Executive and Supervisory Board with clear majorities.
- Zwingenberg (Germany), 8 March, 2023 – At the Annual General Meeting of BRAIN Biotech AG today (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), shareholders approved all proposals of the Executive and Supervisory Board with clear majorities.
- New supervisory board elections by the Annual General Meeting had become necessary to fill a total of three Supervisory Board mandates.
- Following the Annual General Meeting, the Supervisory Board of BRAIN Biotech AG elected in its constituent meeting Dr. Michael Majerus as its new Chairman.
- The detailed voting results as well as the presentations of the Executive Board and all other documents relating to the Annual General Meeting are available on the BRAIN Biotech AG website: